Skip to main
SIBN
SIBN logo

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc. has demonstrated strong financial performance, with a notable gross margin increase of approximately 80 basis points year-over-year, reaching 79.8% in the second quarter of 2025. Revenue growth was significant, up around 23% year-over-year to $46.4 million, reflecting strong demand for its proprietary surgical implant systems. Additionally, the company experienced a 25% year-over-year increase in the number of surgeons utilizing its products, indicating robust market traction and effective sales efforts.

Bears say

SI-BONE Inc. faces significant challenges due to persistent pricing and procedural headwinds within the global spine market, which have resulted in growth slowing to the low-single digits. Additionally, if payors opt to reimburse for competitive products, SI-BONE's market share in the sacroiliac joint fusion market may decline, further impacting the company's revenue potential. Overall, expectations indicate that these unfavorable conditions are likely to persist, casting doubt on the company's ability to achieve sustainable growth.

SI-BONE Inc (SIBN) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Buy based on their latest research and market trends.

According to 4 analysts, SI-BONE Inc (SIBN) has a Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.